chrisvoncsefalvay/vaers-outcomes huggingface dataset:
got bit by a dog; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) (Batch/Lot number: unknown) as dose 1, single for immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Pneumovax (she received her first Pneumovax dose), administration date: 19Oct2020, for immunization; Moderna covid vaccine (she received the Moderna Covid vaccine back in Feb and March.), administration date: Feb2021, for immunization; Moderna covid vaccine (she received the Moderna Covid vaccine back in Feb and March.), administration date: Mar2021, for immunization; Rabies shot (back in April and got a rabies shot), administration date: Apr2021, for immunization. The following information was reported: ANIMAL BITE (non-serious) with onset Apr2021, outcome "unknown", described as "got bit by a dog". Therapeutic measures were taken as a result of animal bite.  Additional information: caller reported that after getting the Moderna Covid vaccine she got bit by a dog and had to get a rabies shot.Caller was unsure which Pneumovax brand she had received (either Prevnar 13 or PPSV23). Spoke from Prevnar 13 Vaccination Schedule for Adults 18 Years of Age and Older. Prevnar 13 is administered as a single dose. During this call the caller also asked if this agent had any information on rabies vaccines stating that she got bit by a dog a couple of months ago, back in April and got a rabies shot (unsure if it was a Pfizer product).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This case was reported by a healthcare professional and described the occurrence of elevated liver enzymes in a 31 year old female subject who was vaccinated with Twinrix for prophylaxis. The subjects medical history included Hep C. There were no concurrent medications. On 4/27/06, the subject received 1st dose of Twinrix. On 8/29/06 4 months after vaccination with Twinrix, it was noted that the subject had developed elevated liver enzymes. As a result of this event, the immunization series with Twinrix was discontinued. This case was assessed as medically serious by manufacturer (OMIC). At the time of reporting the event was unresolved.
Systemic: Headache-Severe, Systemic: Hypertension-Severe
Pt states she started having "tightness" in her throat about 1 hour after recieving the vaccine, this continued to get worse with chest tightness and shortness of air until after she got home. Pt states she had her neighbor take her to the emergency department at this point.
Intense body heat, I also feel like I am without air. As though I am suffocating. I also feel as though I?m itching and burning within. I feel it is unrelated to my menopause, for the heat is way more intense than I have ever felt before.
DRY EYES; PAIN IN NECK; LETHARGIC; FELT ROUGH; PAIN IN RIGHT ARM/TENDER LEFT ARM; PAIN IN SHOULDER; WEAKNESS; DRAINED/TIREDNESS; PAIN IN HEAD/HEADACHE; BURNING SENSATION AT THE SITE OF VACCINATION; FLUTTER IN RIGHT WRIST; INJURY IN RIGHT WRIST; This spontaneous report received from a patient concerned a 56 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included cigarette smoker, and allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 04A21A, expiry: UNKNOWN) dose was not reported, administered on 10-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced injury in right wrist. On 10-APR-2021, the subject experienced flutter in right wrist. On 10-APR-2021, the subject experienced burning sensation at the site of vaccination. On 11-APR-2021, the subject experienced dry eyes. On 11-APR-2021, the subject experienced pain in neck. On 11-APR-2021, the subject experienced lethargic. On 11-APR-2021, the subject experienced felt rough. On 11-APR-2021, the subject experienced pain in right arm/tender left arm. On 11-APR-2021, the subject experienced pain in shoulder. On 11-APR-2021, the subject experienced weakness. On 11-APR-2021, the subject experienced drained/tiredness. On 11-APR-2021, the subject experienced pain in head/headache. On 11-APR-2021 10:00, treatment medications included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from dry eyes, pain in neck, pain in shoulder, and pain in head/headache on 12-APR-2021, lethargic, and weakness on 13-APR-2021, and flutter in right wrist on 10-APR-2021, had not recovered from pain in right arm/tender left arm, and the outcome of burning sensation at the site of vaccination, felt rough, drained/tiredness and injury in right wrist was not reported. This report was non-serious.
Spinal fusion back surgery with cage insertion; This case was reported by a consumer via call center representative and described the occurrence of spinal fusion surgery in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 21st November 2019, the patient received the 1st dose of Shingrix (intramuscular). On 21st February 2020, 92 days after receiving Shingrix, the patient experienced spinal fusion surgery (serious criteria hospitalization). On an unknown date, the outcome of the spinal fusion surgery was unknown.   It was unknown if the reporter considered the spinal fusion surgery to be related to Shingrix.  Additional information was provided as follows: The patient went through a spinal fusion back surgery with cage insertion. The patient was hospitalized for total of one day, and discharged next day. The reporter consented to follow up. No other details were provided. This case had been linked with US2020079555, reported by same reporter.
tinnitus,  in June i began to hear a constant low rumbling hum, at first i assumed it was something in the house or outside, but have ruled out external noise, i notice it mostly at night when it is quiet more recently, perhaps september i also began to hear a faint high pitched ringing sound, again more noticeable when it is quiet the low hum seems to localize left while the high pitched ringing seems to localize right
After 30 minutes I became extremely tired, this lasted for 24hrs. I was very fatigued. The injection site also became red and swollen. The surrounding skin started to peel. This started after 3 hours and is still occurring.
This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days since the first dose and the patient has not received the second dose), HYPERSENSITIVITY (allergic reaction), URTICARIA (hives), PRURITUS (itching really bad) and RASH (rash) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination. No Medical History information was reported. On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced HYPERSENSITIVITY (allergic reaction), URTICARIA (hives), PRURITUS (itching really bad) and RASH (rash). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days since the first dose and the patient has not received the second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (It has been more than 36 days since the first dose and the patient has not received the second dose) had resolved and HYPERSENSITIVITY (allergic reaction), URTICARIA (hives), PRURITUS (itching really bad) and RASH (rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication reported. No treatment information was provided. Reporter did not allow further contact. Most recent FOLLOW-UP information incorporated above includes: On 09-Aug-2021: live follow up: missed dose event added.
Fever, chills, body aches x 48 hours, headache, nausea, brain fog, fatigue x 7 days,  on and off acid reflux, dizziness, lightheaded ness
This non-serious spontaneous case, initially received from other non-health professional on 02-Nov-2018, concerns an 83-year-old, elderly patient of an unspecified gender. It was reported that, the FLUAD (TIV) vaccine underwent temperature excursion for the first time. The vaccine was out for around 48 hours and it reached 11.6 degree Celsius (explicitly coded as incorrect product storage). On 11-Oct-2018, the patient was administered FLUAD (TIV), [route of administration: intramuscular, anatomical location: left deltoid, batch number: 250795, expiry date: 30-Apr-2019 and dose: not reported] which underwent temperature excursion (explicitly coded as drug administration error). At the time of this report, no adverse event was reported. This case 201805494 was crossed linked to original case 201804863 due to same reporter.
Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 019B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021 at 2:02 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 27-Mar-2021 at 2:02 PM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 81.40 years.  Concomitant products were not provided.  On 23-Mar-2021, the vaccine with batch number 019B21A was moved to fridge. On 27-Mar-2021, 20 vials were moved to the clinic. Between 09 AM to 10 AM, vials underwent temperature excursion with temperature of 35 degrees Fahrenheit.  The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 22-Apr-2021.   It was reported that, the storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  It was reported that, the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree Fahrenheit.  Treatment medications were not reported.
Patient received 2 doses of the Moderna COVID-19 vaccine from our pharmacy. First dose on 6/25/21, second dose on 7/23/21. Patient was screened using the CDC COVID-19 vaccine screening questionnaire and answered "no" to previous COVID-19 vaccinations. Patient's insurance paid for both vaccinations insurance claims. Both doses were reported. No evidence of previous COVID-19 vaccination were apparent until we were logging her 2nd dose from our facility. Upon further investigation of the patient's vaccine history, she received 2 doses of Moderna COVID-19 vaccine from a different facility on 4/30/21 and 5/28/21.  In summary, the patient has received 4 doses of the Moderna COVID-19 vaccine. The patient denied receiving any previous COVID-19 vaccinations upon our questioning.
FEVER (102.1), CHILLS, FELT LIKE I WAS HIT BY A TRUCK (SEVERE MUSCLE ACHES), FATIGUE, ALL OVER RASH AND ITCHINESS WITH LITTLE BUMPS. I TOOK 2 EXTRA STRENGTH EXCEDRIN AT MIDNIGHT  WITHOUT MUCH EFFECT THEN TOOK NYQUIL THREE HOURS LATER AT 3AM (I STILL HAVE RASH AND ITCHINESS BUT EVERYTHING ELSE BETTER)
5 minutes after vaccination patient stated she had a 4/10 h/a,pain in the back of her head, and feeling hot.  Pt was seen for an appt at 0908 where her blood pressure was 109/70 and temp was 97.8 after vaccines pt's bp was 129/80 and temp was 100.8.  10 minutes after shot pt states she is feeling better with a 2/10 headache, bp 116/72, temp 100.8.
Weakness, fever (101 degree F), nausea 09/18/09.  Sore throat on 09/17/09 dizziness, headache.
Pt developed axillary temp of 107 degrees 30 hours after receiving vaccines. Pt felt hot and was very fussy and crying. 1 hour after Tylenol the pt's temp was 98.8.
sore arm; itch; burning sensation; rash; joint pain in shoulders; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PRURITUS (itch), BURNING SENSATION (burning sensation), RASH (rash) and ARTHRALGIA (joint pain in shoulders) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), PRURITUS (itch), BURNING SENSATION (burning sensation), RASH (rash) and ARTHRALGIA (joint pain in shoulders). At the time of the report, PAIN IN EXTREMITY (sore arm), PRURITUS (itch), BURNING SENSATION (burning sensation), RASH (rash) and ARTHRALGIA (joint pain in shoulders) outcome was unknown.            No concomitant medication was reported.  No treatment medication was reported.  Action taken with mRNA-1273 with respect to events was not applicable.   This case was linked to MOD-2021-059762 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Additional information received for patient's demographics and age details.
I have had an enlarged and painful thyroid for 48 hours starting 10 days after my COVID 19 booster shot.
Swollen  arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen  arm) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen  arm). At the time of the report, PERIPHERAL SWELLING (Swollen  arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Initial unsolicited report received from a non-health care professional via Pfizer on 24 November 2015. This case involves a (71-year-old) male patient who was vaccinated with a [route and dose series not reported] injection dose of FLU SHOT (batch number, expiry date and site of administration were not reported), received PREVNAR (manufacturer Pfizer, batch number, expiry date and site of administration were not reported) on 19 October 2015 and also received 20 mg three times a day dose of REVATIO (manufacturer Pfizer, batch number, expiry date and site of administration were not reported) on August 2013. Medical history were congestive heart failure, heart surgery, heart catheterization, pulmonary hypertension, sleep apnea, connective tissue disease, overlap syndrome, hardening of the arteries in his heart. Concomitant medication were Lisinopril 50mg once a day for high blood pressure, Lipitor for Cholesterol, aspirin, metformin 850mg once a day for Diabetes, Lasix 40mg once a day, amlodipine 10mg once a day, letairis, bystolic 10mg once a day, spironolactone 25mg once a day and treprostinil three puffs inhalation four times a day. On an unspecified date of October 2015, 10 days following the vaccination patient experienced Flu-like symptoms. On an unspecified date of October 2015, following the vaccination patient also experienced No appetite, Coughing, Mucus, He swells and patient is ill/ patient never has gotten sick like this before. It was also reported that, patient did not require an emergency room or doctor visit. Patient laboratory investigation was not reported. Corrective treatment was oxygen for mucus. The outcome of event was recovering Flu-like symptoms, No appetite, Coughing, recovered for Mucus and unknown for He swells and patient is ill/ patient never has gotten sick like this before. List of documents held by sender: none.
A non-serious spontaneous report of tongue turned black and lost taste bud has been received from a health professional concerning a 13-year-old female, subsequent to FLUMIST. No relevant past medical history had been reported for this patient. Concomitant medications included vaccines for varicella and Hep A given on 20-Oct-2011. On 20-Oct-2011, the patient received FLUMIST. An hour after receiving FLUMIST, the patient's tongue turned black and she lost her taste buds. These events lasted for few hours and got resolved by at 4 pm on 20-Oct-2011. The events of tongue turned black and lost taste bud resolved.
I woke up around 11:30p (1/15) with aching in my legs. I took some Tylenol a d laid back down. I became restless and tossed and turned. My body started aching and by morning (7a 1/16) I had a blinding headaches, body and joint pain and a fever of 101.8. This continued throughout the day 1/16. I also had chills. My fever broke around 2am 1/17 and the body aches went away. I have had a headache  and fatigue today (1/17).
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent conditions, or concomitant medication. On or about 17-AUG-2015, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided) at a health care facility/office "routine health maintenance and for the prevention of shingles." The vaccine did not prevent shingles, but rather caused the patient to contract a persistent strain of herpes zoster. Shortly after receiving ZOSTAVAX vaccine, the patient was diagnosed as suffering from shingles. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX.  The outcome of the events was unknown. Additional information has been requested.
Patient had swelling and extreme pain in the right arm. He also had fever. Patient went to ER.
I received the vaccine at 11:50 am. First my arm started hurting and felt warm to the touch shortly after the injection. My arm started hurting more and more until I could barely lift it to the side more than like 20 degrees from my side.  Then I got the worst headache of my life. I tried taking ibuprofen, but it barely seemed to make any difference. I also tried taking Bayer aspirin and it seemed to help a little bit. Plus the whole time I was feeling nauseas, and it was all I could do to eat a few crackers so the medicine wouldn't upset my stomach as much. By this time the muscle/body aches, and fatigue started setting in so I just tried to go to sleep around 8pm or so. I was able to sleep, but it wasn't a restful sleep. I was tossing and turning for a few hours. Then the chills set in around 10pm and I didn't want to get out from under the covers because I was shaking so bad. But I managed to pile enough blankets on to get warm, and I was able to get some sleep. Then next day, all of the previous symptoms seemed to get worse except for the chills seemed come and go. But my arm was hurting more in a larger area and up my shoulder. The muscle/body aches were more intense and the fatigue increased. Taking Ibuprofen every few hours only marginally seemed to help. My head was hurting so bad it hurt to open my eyes. And I felt like I was going to throw up all day. Plus I started taking my temp sometime in the morning of over 101. Sorry about to run out of time
Information has been received from a nurse practitioner concerning a 22 year old female with penicillin allergy and sulfa allergy and no previous medical history reported who on 24-APR-2008 was vaccinated with the first dose of GARDISAL, IM, and on 26-JUN-2008 was vaccinated with the second dose of GARDISAL 0.5ml. Concomitant therapy included LOESTRIN. On 26-JUN-2008, after receiving the second vaccination, the patient experienced fever. On an unspecified date, the patient recovered from fever. The patient sought medical attention by spoke to the nurse practitioner. Additional information has been requested.
Administration of an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration of an expired vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Swelling of left upper arm, the size of a tennis ball. Treated with cold compresses and Tylenol/Advil to be used.